OTTMUSG00000018888 Activators
Gm15056 represents a category of proteins whose functions, interactions, and cellular roles have not yet been elucidated. This classification highlights the vast unknowns within the proteomic landscape, where numerous proteins await functional characterization to understand their contributions to cellular physiology and organismal biology. The challenge of identifying activators for such proteins underscores the complexity of biological systems and the need for comprehensive approaches to unravel the functions and regulatory mechanisms of uncharacterized proteins. Understanding the roles of these proteins could significantly advance our knowledge of cellular processes, and disease mechanisms.
Activation mechanisms for proteins, in general, involve a range of biochemical and cellular processes, including but not limited to post-translational modifications (PTMs), changes in subcellular localization, alterations in protein stability, and modifications in protein-protein interactions. PTMs, such as phosphorylation, acetylation, ubiquitination, and methylation, serve as regulatory switches that can activate or deactivate protein functions, influencing cellular signaling, gene expression, and metabolic pathways. The interactions between proteins and other molecules, including DNA, RNA, lipids, and small molecular ligands, further modulate protein activity, contributing to the dynamic regulation of cellular states and responses to environmental cues. For uncharacterized proteins like Gm15056, identifying the specific activators and their mechanisms of action requires detailed studies of the protein's structure, localization, interacting partners, and involvement in cellular pathways. Such investigations would provide valuable insights into the protein's function and its potential roles in health and disease, paving the way for the development of targeted interventions to modulate its activity. As science advances, the exploration of uncharacterized proteins will continue to be a frontier of biomedical research, offering opportunities to discover novel biological mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic catecholamine, engages β-adrenergic receptors, triggering adenylate cyclase activation and cAMP production. This surge in cAMP potentially enhances PKA activity, which could phosphorylate and activate the uncharacterized protein LOC100504014 precursor, suggesting its role in β-adrenergic signaling cascades. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP degradation, thereby sustaining its cellular levels. Elevated cAMP promotes PKA activity, possibly leading to the phosphorylation and activation of uncharacterized protein LOC100504014 precursor, indicating its involvement in cAMP-responsive pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with both α and β-adrenergic receptors, causing adenylate cyclase activation and increased cAMP levels. This elevation might enhance PKA activity, which in turn could phosphorylate and activate the uncharacterized protein LOC100504014 precursor, integrating it into adrenergic signal transduction. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) binds to its EP receptor subtypes, leading to adenylate cyclase activation and cAMP accumulation. This increase in cAMP may activate PKA, which could phosphorylate and activate uncharacterized protein LOC100504014 precursor, suggesting its involvement in prostaglandin-mediated signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective inhibitor of phosphodiesterase 4, elevates intracellular cAMP by preventing its breakdown. Higher cAMP levels can activate PKA, potentially leading to phosphorylation and activation of uncharacterized protein LOC100504014 precursor, linking it to cAMP/PKA signaling mechanisms. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin, a protein synthesis inhibitor, can indirectly activate stress-activated protein kinases (SAPKs), which may influence the activity of various cellular proteins. This activation pathway could implicate the uncharacterized protein LOC100504014 precursor in stress response mechanisms via post-translational modifications. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits phosphodiesterases, leading to increased cAMP levels, which in turn enhances PKA activity. This mechanism might facilitate the phosphorylation and subsequent activation of uncharacterized protein LOC100504014 precursor, indicating its potential role in metabolic regulation and stress response pathways. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride acts as a nonspecific activator of adenylyl cyclases, resulting in elevated cAMP levels. This increase may boost PKA activity, potentially leading to phosphorylation and activation of uncharacterized protein LOC100504014 precursor, suggesting a role in fluoride-responsive cellular processes. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast selectively inhibits phosphodiesterase 5 (PDE5), leading to increased cAMP and cGMP levels. The elevated cAMP could enhance PKA activity, potentially phosphorylating and activating uncharacterized protein LOC100504014 precursor, implicating it in cyclic nucleotide signaling. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
Calcium dibutyryladenosine cyclophosphate is a cell-permeable cAMP analog that directly activates PKA. By bypassing cellular receptors and adenylyl cyclase activation, dbcAMP may directly enhance PKA-mediated phosphorylation and activation of uncharacterized protein LOC100504014 precursor, indicating a direct route to activation. | ||||||